⌘K

Login Start Free

Home/Filings/4/0001569706-18-000002

4//SEC Filing

Averback Paul 4

Accession 0001569706-18-000002

CIK 0001018735other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:26 PM ET

Size

4.5 KB

Accession

0001569706-18-000002

Insider Transaction Report

Form 4

Period: 2018-10-29

NYMOX PHARMACEUTICAL CORPNYMX

DirectorCEO10% Owner

Transactions

Sale
Restricted common
2018-10-29$2.50/sh−1,687,600$4,219,000→ 21,643,948 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NYMOX PHARMACEUTICAL CORP

CIK 0001018735

Entity typeother

Related Parties

1

filerCIK 0001569706

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 5:26 PM ET
Size: 4.5 KB

View on SEC.gov